FDA NDC Directory · JSON-LD · Markdown
NDC 71839-122 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, FOR SOLUTION
| Labeler / Manufacturer | BE Pharmaceuticals Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA216171 |
| Dosage form / route | INJECTION, POWDER, FOR SOLUTION · INTRAVENOUS |
| Active ingredients | PANTOPRAZOLE SODIUM (40 mg/10mL) |
| Marketing started | 20220525 |
| Package count | 3 |
Source: openFDA. Public-domain (CC0).